Session » (0049–0066) Rheumatoid Arthritis – Animal Models Poster

Date: Sunday, October 26, 2025

Time: 10:30AM-12:30PM

Meeting: ACR Convergence 2025

10:30AM-12:30PM: Abstract Number: 0060

Dietary Management of Rheumatoid Arthritis: A Functional Investigation of the Synbiotic Medical Food, SBD121

10:30AM-12:30PM: Abstract Number: 0063

Effect of alpha-ketoglutarate on Synovial Fibroblasts-Mediated Inflammation in Arthritis

10:30AM-12:30PM: Abstract Number: 0049

Enhanced Src Homology Region 2 Domain-containing Phosphatase 1 Activity Ameliorates Murine Inflammatory Arthritis Through the Innate Immune System

10:30AM-12:30PM: Abstract Number: 0065

Expression and Co-Localization of Malondialdehyde-Acetaldehyde and Citrullinated Proteins in Myocardial Tissues Precedes the Development of Cardiac Fibrosis in Collagen-Induced Arthritis

10:30AM-12:30PM: Abstract Number: 0059

Formyl Peptide Receptor 1 (FPR1) Influences Arthritis Severity in a Sex- and Compartment-Specific Manner

10:30AM-12:30PM: Abstract Number: 0061

IL-22 Contributes to Autoantibody-induced Arthritis Via Modulation of Inflammatory Cytokine and Chemokine Expression in the Inflamed Synovium of a Murine Model

10:30AM-12:30PM: Abstract Number: 0054

Microbial Cues Promote Arthritis and Alter T Cell Selection in SKG Mice

10:30AM-12:30PM: Abstract Number: 0062

Neddylation as a Therapeutic Target in Autoimmune Arthritis: Evidence from SKG Mice

10:30AM-12:30PM: Abstract Number: 0052

Profiling of MT-3534, a Humanized Monoclonal Antibody Targeting Peptidylarginine Deiminase 4, as a Candidate Drug for the Treatment of RA

10:30AM-12:30PM: Abstract Number: 0066

RA-required synovial tissue-resident monocyte lineage cells are comprised of three distinct subpopulations.

10:30AM-12:30PM: Abstract Number: 0056

Repository Corticotropin Injection Reduces Inflammation and Bone Turnover Markers in the Murine CIA Model

10:30AM-12:30PM: Abstract Number: 0064

Sclerostin from marrow adipogenic precursors is essential for bone and joint homeostasis in mice

10:30AM-12:30PM: Abstract Number: 0051

Spp1+ Macrophages Are Specifically Enriched in Arthritic Joints and Associated with Abnormal Bone Metabolism in Collagen-Induced Arthritis Mice

10:30AM-12:30PM: Abstract Number: 0055

TCR Signaling Thresholds Govern Anergy and Tolerance in ZAP70 Hypomorphic Models of Autoimmune Arthritis

10:30AM-12:30PM: Abstract Number: 0053

The Integrin Inhibitor Cilengitide Targets CCN1-Mediated Angiogenesis and Reduces Disease Severity in a Preclinical Rheumatoid Arthritis Model

10:30AM-12:30PM: Abstract Number: 0050

TL1A expression is upregulated in rheumatic diseases and anti-TL1A antibody reduces disease symptoms and pathological changes in rat collagen-induced arthritis

10:30AM-12:30PM: Abstract Number: 0057

TNF Inhibition with Small-molecule Agents Results in Amelioration of Inflammation Similar to that of Anti-TNF Biologics While Preserving TNFR2 Signaling and Maintaining a Suppressive Regulatory T cell Phenotype

10:30AM-12:30PM: Abstract Number: 0058

Training for increased inflammatory arthritis in mice is not modulated by type 1 interferon

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].